Skip to main content
BIP logo

November 20, 2026

Internal newsletter of the Institut Pasteur

Institut Pasteur
  • Français
  • English
PASTEUR2030

Advocating for medical research and French sovereignty in the Senate

Image
bandeau_neutre_2.png

 

On November 13, a major institutional conference was held in the French Senate, under the high patronage of Senate President Gérard Larcher, to discuss priorities for biomedical research in France over the next decade and how to safeguard French sovereignty in the field.

The conference, held in collaboration with the French Foundation for Medical Research (FRM), was attended by several stakeholders from the fields of research, economics, finance, industry, innovation and knowledge transfer, as well as members of parliament. It was an opportunity for the leaders of the five scientific institutes that co-organized the event – including the Institut Pasteur – to engage in crucial discussions about the strategic challenges facing the French biomedical research ecosystem.

Institut Pasteur President Yasmine Belkaid, alongside Fabrice Barlesi, Director General of Gustave Roussy, Stéphanie Debette, Executive Director of the Paris Brain Institute, Bana Jabri, Director of the Imagine Institute, and Alain Puisieux, Chairman of the Institut Curie's Executive Board, took to the floor to share thoughts on the plethora of scientific talent in France and the fact that French research has never been so close to a "biomedical revolution" that will make a real difference to patients' lives. Unfortunately, however, "basic research is all but absent from the political debate and is suffering from chronic under-investment."

During the discussions, the leaders shared their views and called for commitments on various fronts including investment in research, cooperation on major health priorities and promoting scientific culture.

 

Image
©Institut Gustave Roussy


See the LinkedIn post by Institut Pasteur President Yasmine Belkaid during the conference in the Senate on November 13. This initiative was part of the Institut Pasteur's broader advocacy efforts for biomedical research in the run-up to next year's presidential election.

<<< Retour
  • BIP Archives
  • Contact